Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment.
Valeant will...

Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.
The Irvine company's...

It's only June, but already the Mohegans are looking forward to New Year's Day.
That's because the dawn of 2015 will mark the end of the tribe's so-called "relinquishment agreement" with its original partners, Trading Cove Associates, the people...

The jockeying for control of Botox maker Allergan Inc. is getting nastier.
Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors. He wants shareholders to dump six unnamed directors.
The move is the latest gambit by Ackman to ramp up pressure on Allergan to acquiesce to an unsolicited buyout offer. Ackman has teamed with Canadian drug maker Valeant Pharmaceuticals International...

The jockeying for control of Botox maker Allergan Inc. is getting downright hostile — and even more bizarre.
Activist investor Bill Ackman called for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors. He wants shareholders to dump six unnamed directors.
It's the latest move by Ackman and Valeant Pharmaceuticals International Inc. to pressure Allergan to acquiesce to an unsolicited buyout offer. The hedge-fund manager...

The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders.
Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to reject a buyout offer from Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.
Speaking at Allergan's annual meeting in Irvine, Herbert told the board that he feared Valeant would cut the company's research and development budget...

Leveraged Buyouts Photos

Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders.
Last month, the Irvine drugmaker received an unsolicited buyout offer from Valeant and activist shareholder Bill Ackman. As a defense, Allergan adopted a poison pill strategy to slow down the potential takeover, then reportedly pursued other buyers.
Under the offer, Allergan stockholders would receive $48....

Bobby Kotick, chief executive at video game publisher Activision Blizzard Inc. (think "Call of Duty" and "World of Warcraft"), saw his job threatened last year when he refused to accept the sale of some of Activision's shares to anyone but a group he controlled, according to court documents.
Kotick, Activision Chairman Brian Kelly and their group ended up buying a $2.3-billion stake in Activision from Vivendi SA in a deal that other Activision shareholders are targeting in a lawsuit.
Last month, a...

Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival.
Stung by criticism that it's too fat, Allergan will slash about 650 research-and-development employees, many of them high-paying scientists based in Irvine. The company is also closing facilities in Santa Barbara and Carlsbad, Calif., where a combined 400 employees work.
Allergan...